Answers are grounded in this paper and cite their sources.
Meta-analysis demonstrates improved functional outcomes and lower mortality in acute ischemic stroke, indicating recanalization is a valid therapeutic biomarker.
Formal meta-analysis confirms a strong correlation between recanalization and outcome in acute ischemic stroke. Recanalization is strongly associated with improved functional outcomes and reduced mortality. These findings suggest that recanalization is an appropriate biomarker of therapeutic activity in early phase trials of thrombolytic treatment in acute ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Rha et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: